ENVISTA HOLDINGS CORP (NVST)
US29415F1049 - Common Stock
Taking everything into account, NVST scores 4 out of 10 in our fundamental rating. NVST was compared to 187 industry peers in the Health Care Equipment & Supplies industry. NVST has an average financial health and profitability rating. NVST has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year NVST was profitable.
NVST had a positive operating cash flow in the past year.
NVST had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NVST had a positive operating cash flow.
1.2 Ratios
NVST has a Return On Assets of -24.27%. This is comparable to the rest of the industry: NVST outperforms 49.46% of its industry peers.
Looking at the Return On Equity, with a value of -43.52%, NVST is in line with its industry, outperforming 52.69% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.94%, NVST is in the better half of the industry, outperforming 72.04% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NVST is below the industry average of 8.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.27% | ||
| ROE | -43.52% | ||
| ROIC | 2.94% |
ROA(3y)2.45%
ROA(5y)2.27%
ROE(3y)3.92%
ROE(5y)3.76%
ROIC(3y)5.53%
ROIC(5y)4.57%
1.3 Margins
Looking at the Operating Margin, with a value of 6.50%, NVST is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
In the last couple of years the Operating Margin of NVST has grown nicely.
The Gross Margin of NVST (54.20%) is comparable to the rest of the industry.
NVST's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.5% | ||
| PM (TTM) | N/A | ||
| GM | 54.2% |
OM growth 3Y16.44%
OM growth 5Y3.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y0.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NVST is destroying value.
The number of shares outstanding for NVST has been increased compared to 1 year ago.
Compared to 5 years ago, NVST has more shares outstanding
Compared to 1 year ago, NVST has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.44, we must say that NVST is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.44, NVST perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
NVST has a debt to FCF ratio of 5.21. This is a neutral value as NVST would need 5.21 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.21, NVST is doing good in the industry, outperforming 78.49% of the companies in the same industry.
A Debt/Equity ratio of 0.42 indicates that NVST is not too dependend on debt financing.
NVST has a Debt to Equity ratio (0.42) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 5.21 | ||
| Altman-Z | 1.44 |
ROIC/WACC0.34
WACC8.63%
2.3 Liquidity
NVST has a Current Ratio of 2.08. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.08, NVST is not doing good in the industry: 65.05% of the companies in the same industry are doing better.
NVST has a Quick Ratio of 1.77. This is a normal value and indicates that NVST is financially healthy and should not expect problems in meeting its short term obligations.
NVST's Quick ratio of 1.77 is in line compared to the rest of the industry. NVST outperforms 44.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.68%.
The Earnings Per Share has been growing by 16.41% on average over the past years. This is quite good.
The Revenue has decreased by -3.04% in the past year.
Measured over the past years, NVST shows a decrease in Revenue. The Revenue has been decreasing by -2.04% on average per year.
EPS 1Y (TTM)-55.68%
EPS 3Y16.41%
EPS 5YN/A
EPS Q2Q%-72.09%
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y9.98%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.8%
3.2 Future
NVST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.46% yearly.
The Revenue is expected to grow by 6.29% on average over the next years.
EPS Next Y-52.08%
EPS Next 2Y-13%
EPS Next 3Y-4.37%
EPS Next 5Y13.46%
Revenue Next Year-2.07%
Revenue Next 2Y0.36%
Revenue Next 3Y1.39%
Revenue Next 5Y6.29%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.15, the valuation of NVST can be described as expensive.
83.87% of the companies in the same industry are more expensive than NVST, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.40, NVST is valued at the same level.
With a Price/Forward Earnings ratio of 16.94, NVST is valued correctly.
87.63% of the companies in the same industry are more expensive than NVST, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NVST to the average of the S&P500 Index (23.67), we can say NVST is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.15 | ||
| Fwd PE | 16.94 |
4.2 Price Multiples
NVST's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVST is cheaper than 88.71% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 95.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.38 | ||
| EV/EBITDA | 12.74 |
4.3 Compensation for Growth
NVST's earnings are expected to decrease with -4.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13%
EPS Next 3Y-4.37%
5. Dividend
5.1 Amount
NVST does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ENVISTA HOLDINGS CORP
NYSE:NVST (1/6/2025, 7:00:00 PM)
After market: 20.37 +0.75 (+3.82%)19.62
+0.59 (+3.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners112.09%
Inst Owner Change0%
Ins Owners0.61%
Ins Owner Change3.36%
Market Cap3.38B
Analysts71
Price Target21.76 (10.91%)
Short Float %6.57%
Short Ratio5.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.03%
Min EPS beat(2)-59.95%
Max EPS beat(2)29.88%
EPS beat(4)1
Avg EPS beat(4)-16.41%
Min EPS beat(4)-59.95%
Max EPS beat(4)29.88%
EPS beat(8)3
Avg EPS beat(8)-9.52%
EPS beat(12)6
Avg EPS beat(12)-5.32%
EPS beat(16)10
Avg EPS beat(16)3.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-4.06%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-2.42%
Revenue beat(12)1
Avg Revenue beat(12)-2.06%
Revenue beat(16)1
Avg Revenue beat(16)-3.85%
PT rev (1m)-0.98%
PT rev (3m)17.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-34.63%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)2.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.15 | ||
| Fwd PE | 16.94 | ||
| P/S | 1.35 | ||
| P/FCF | 12.38 | ||
| P/OCF | 11.03 | ||
| P/B | 1.1 | ||
| P/tB | 79.26 | ||
| EV/EBITDA | 12.74 |
EPS(TTM)0.78
EY3.98%
EPS(NY)1.16
Fwd EY5.9%
FCF(TTM)1.58
FCFY8.08%
OCF(TTM)1.78
OCFY9.07%
SpS14.55
BVpS17.85
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.27% | ||
| ROE | -43.52% | ||
| ROCE | 3.5% | ||
| ROIC | 2.94% | ||
| ROICexc | 3.73% | ||
| ROICexgc | 21.86% | ||
| OM | 6.5% | ||
| PM (TTM) | N/A | ||
| GM | 54.2% | ||
| FCFM | 10.89% |
ROA(3y)2.45%
ROA(5y)2.27%
ROE(3y)3.92%
ROE(5y)3.76%
ROIC(3y)5.53%
ROIC(5y)4.57%
ROICexc(3y)6.59%
ROICexc(5y)5.35%
ROICexgc(3y)175.29%
ROICexgc(5y)N/A
ROCE(3y)6.59%
ROCE(5y)5.46%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-3.72%
ROICexc growth 3Y22.76%
ROICexc growth 5Y3%
OM growth 3Y16.44%
OM growth 5Y3.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y0.07%
F-Score3
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 5.21 | ||
| Debt/EBITDA | 4.49 | ||
| Cap/Depr | 26.05% | ||
| Cap/Sales | 1.33% | ||
| Interest Coverage | 2.68 | ||
| Cash Conversion | 105.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 1.44 |
F-Score3
WACC8.63%
ROIC/WACC0.34
Cap/Depr(3y)47.37%
Cap/Depr(5y)47.73%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.68%
EPS 3Y16.41%
EPS 5YN/A
EPS Q2Q%-72.09%
EPS Next Y-52.08%
EPS Next 2Y-13%
EPS Next 3Y-4.37%
EPS Next 5Y13.46%
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y9.98%
Revenue growth 5Y-2.04%
Sales Q2Q%-4.8%
Revenue Next Year-2.07%
Revenue Next 2Y0.36%
Revenue Next 3Y1.39%
Revenue Next 5Y6.29%
EBIT growth 1Y-54.97%
EBIT growth 3Y28.06%
EBIT growth 5Y1.72%
EBIT Next Year-34.09%
EBIT Next 3Y-2.95%
EBIT Next 5Y13.21%
FCF growth 1Y93.54%
FCF growth 3Y-2.71%
FCF growth 5Y-7.88%
OCF growth 1Y46.88%
OCF growth 3Y-0.97%
OCF growth 5Y-7.18%